Regulation of gene expression by the proto-oncogene BCL-6. (Q34498083)

2 August 2017

1 reference

title

Regulation of gene expression by the proto-oncogene BCL-6. (English)

1 reference

2 August 2017

Alexander L Dent

1

1 reference

2 August 2017

Farha H Vasanwala

series ordinal

2

1 reference

2 August 2017

Lisa M Toney

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Critical Reviews in Oncology Hematology

2 August 2017

1 reference

2 August 2017

41

1 reference

2 August 2017

1-9

1 reference

2 August 2017

1

1 reference

Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Rearrangement of the bcl-6 gene in Hodgkin's disease, lymphocyte predominant type

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL6 rearrangement in a patient with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations ofBCL6: Implications for disease pathogenesis and histogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Molecular biology of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The POZ domain: a conserved protein-protein interaction motif

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL6 encodes a sequence-specific DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Recognition DNA sequence of a novel putative transcription factor, BCL6.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

1 reference

7 January 2021

The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

1 reference

7 January 2021

Histone deacetylases, transcriptional control, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Histone deacetylases: silencers for hire.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

STATs: signal transducers and activators of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Control of inflammation, cytokine expression, and germinal center formation by BCL-6

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Disruption of the Bcl6 gene results in an impaired germinal center formation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

1 reference

7 January 2021

The role of Bcl6 in mature cardiac myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

DNA replication progresses on the periphery of nuclear aggregates formed by the BCL6 transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900164-0

7 January 2021

10.1016/S1040-8428(01)00164-0

Identifiers

DOI

1 reference

2 August 2017

1 reference